AI forecasts indicate modest near-term downside risk for DexCom, with negative momentum emerging. Analyst consensus projects upside with strong coverage and moderate spread, reflecting broadly aligned outlooks. This divergence suggests short-term caution balanced by longer-term growth expectations, highlighting risk-return dynamics for investors.